Ikarian-Capital

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
141
Total Value
710178588
Accession Number
0001420506-25-001276
Form Type
13F-HR
Manager Name
Ikarian-Capital
Data Enrichment
96% identified
135 identified6 unidentified

Holdings

141 positions
Manager:
Search and click to pin securities to the top
Page 7 of 8
Anebulo Pharmaceuticals, Inc.
Shares:157.7K
Value:$205.0K
Voyager Therapeutics, Inc.
Shares:55.8K
Value:$188.5K
Elevation Oncology, Inc.
Shares:690.0K
Value:$178.8K
Sensei Biotherapeutics, Inc.
Shares:450.0K
Value:$177.3K
Celcuity Inc.
Shares:14.9K
Value:$150.6K
Evaxion Biotech A/S
Shares:80.0K
Value:$148.0K
Rezolute, Inc.
Shares:50.1K
Value:$145.2K
Lyra Therapeutics, Inc.
Shares:1.1M
Value:$133.6K
Theriva Biologics, Inc.
Shares:120.0K
Value:$132.0K
Larimar Therapeutics, Inc.
Shares:58.5K
Value:$125.8K
Jasper Therapeutics, Inc.
Shares:25.1K
Value:$108.0K
Karyopharm Therapeutics Inc.
Shares:27.3K
Value:$101.9K
MACROGENICS INC
Shares:80.1K
Value:$101.7K
Alpha Teknova, Inc.
Shares:14.0K
Value:$72.7K
Traws Pharma, Inc.
Shares:28.5K
Value:$65.5K
HOOKIPA Pharma Inc.
Shares:53.0K
Value:$57.2K
Sagimet Biosciences Inc.
Shares:12.0K
Value:$39.1K
05330T205
Shares:20.0K
Value:$35.0K
SYNLOGIC, INC.
Shares:20.4K
Value:$25.3K
Neumora Therapeutics, Inc.
Shares:15.5K
Value:$15.5K